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THE OBSERVATION OF CUE-DIRECTED BEHAVIOR IN SIGN-TRACKING 
AND GOAL-TRACKING RATS FOLLOWING IMPLANTATION OF  
DESIGNER RECEPTORS 
 
 
LAUREN LONGYEAR 
 
 
ABSTRACT 
 Increasing evidence that ordinary cues paired with reward can acquire value 
indicates that the incentive properties of rewards are capable of being transferred onto 
cues, making them incentive stimuli. Studies have begun focusing on isolating 
components of the reward circuit involved in imparting incentive salience onto a cue with 
the goal of identifying rats with susceptibilities to drug addiction. Such studies have 
found that under a Pavlovian Conditioned Approach (PCA) paradigm, sign-tracking rats 
are at increased risk for instilling incentive salience onto conditioned stimuli and for 
engaging in drug-related behavior. With better understanding of the neural basis of sign 
tracking and its behavioral aspect of drug seeking comes a better chance of discovering 
treatment methods for drug addiction.  This study examines the potential behavioral 
outcomes of altering the pathway starting in the Ventral Pallidum (VP) and ending in the 
Ventral Tegmental Area (VTA) by using Designer Receptors Exclusively Activated by 
Designer Drugs (DREADDs).  While there is some evidence of an interaction between 
the effects of DREADDs on this neural circuit and behavior, not all results presented here 
reach significance. Additional studies are needed to confirm the hypothesis of specific 
inhibitory DREADDs from the VP to the VTA causing increased amounts of sign 
tracking in rats as a way to assess whether this pathway is implicated in predisposing rats 
to sign-tracking behavior. 
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INTRODUCTION 
Drug Addiction 
 
Drug addiction is defined as compulsive drug taking behavior with a high 
tendency of relapse after withdrawal (Abuse 2016).  It involves uncontrollable and 
irresistible urges to partake in drug-seeking behavior, even if this behavior results in 
adverse outcomes (Everitt and Robbins 2016).  Only a subset of individuals who engage 
in drug use ultimately become addicted to drugs; for this reason, researchers aim to find 
subsets of animals that are predisposed to seek drugs compulsively in order to investigate 
behavioral and neurological markers for addiction (Everitt and Robbins 2016).   
The constant drug seeking of addicted individuals has been modeled in rats using 
various methods.  Reinforcement schedules that measure drug-seeking behavior are 
useful, as they measure the amount of work a rat is willing to perform in order to obtain a 
drug (Belin et al. 2016), (T. E. Robinson and Berridge 1993).  Rats deemed susceptible to 
drug addiction self-administer cocaine despite receiving punishment in the form of 
footshock and will also perform more work in the form of nose pokes in order to obtain a 
reward (Deroche-Gamonet, Belin, and Piazza 2004).  Additionally, when susceptible rats 
undergo prolonged (3 month) Self-Administration (SA) of an addictive drug, then go 
through a period of withdrawal, their drug seeking under the SA paradigm can be 
reinstated when they are primed with the drug they previously self administered or a cue 
associated with it (Deroche-Gamonet, Belin, and Piazza 2004), which corresponds to the 
tendency to relapse.  
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There are many traits and behavioral tendencies that make rats more likely to 
engage in drug seeking, including high impulsivity, high anxiety level and increased 
conditioned approach to stimuli predictive of reward (Belin et al. 2016).  Rats who fall 
under the third category are termed Sign Trackers (STs) (Flagel, Akil, and Robinson 
2009).  In order to introduce this rat grouping, the Pavlovian Conditioned Approach 
(PCA) paradigm will be outlined. 
 
 
Pavlovian Conditioned Approach 
 
In past experiments, rats have undergone Pavlovian Conditioned Approach (PCA) 
training and have afterwards been sorted into groups based on their behavior during trial 
periods that occur randomly throughout the session.  The PCA procedure is a way to 
assess cue-directed motivation in rats (Flagel, 2007).  Rats are placed in a testing 
chamber where a lever is presented for 8 seconds and retracts as a sucrose pellet reward, 
an Unconditioned Stimulus (UCS), is received in a nearby magazine receptacle.  It is 
important to note that the reward delivery occurs in every trial, regardless of the animal’s 
behavior, meaning no work is necessary to receive the sucrose pellet.  Rats learn to 
associate the lever (cue) with the reward, making the lever a Conditioned Stimulus (CS) 
that elicits Pavlovian Conditioned Approach behavior.   
All animals learn to associate the lever with the food reward, but only some, when 
anticipating the reward, will interact with the lever, while others approach the magazine 
during the 8 seconds the cue is presented (Flagel et al. 2007), (Terry E. Robinson et al. 
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2014), (Saunders and Robinson 2010).  Rats that prefer to approach the site of reward, the 
magazine, during lever presentation are termed Goal Trackers (GTs), while rats that 
approach and interact with the lever (cue) are called Sign Trackers (STs) (Meyer et al. 
2012).  Some rats oscillate between interacting with the lever and the magazine and are 
therefore termed Intermediates (INTs) (Meyer et al. 2012).  Lever interaction varies but 
includes lever presses, sniffing the lever and biting the lever (Flagel et al. 2007).  The 
lever gains value over time in sign trackers, but not in goal trackers, who instead value 
the reward itself (Flagel et al. 2007).  The reason sign trackers approach and value a 
signal for reward rather than the reward itself may be due to the Conditioned Stimulus 
acquiring incentive salience (Saunders and Robinson 2010).   
   
 
          
Figure 1 – Sign Tracker and Goal Tracker: Video capture of a Sign Tracker (left) and 
Goal Tracker (right) engaging in cue-directed behavior during a PCA trial.  The lever, 
also known as the cue or Conditioned Stimulus (CS) is circled in both images. 
Reference: (Flagel, Akil, and Robinson 2009) 
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Incentive Salience 
 
The incentive sensitization theory of addiction suggests that repeated exposure to 
addictive drugs causes some individuals to become sensitized, or hyper reactive, to 
environmental stimuli associated with drugs, thereby making relapse behavior more 
likely in the presence of these environmental stimuli (T. E. Robinson and Berridge 1993).   
According to the incentive sensitization theory, following Pavlovian Conditioning 
where a stimulus is paired with a reward, susceptible individuals attribute incentive 
salience to the Conditioned Stimulus, so that it transforms from a mere predictor of 
reward to an attractive and motivating ‘incentive stimulus’ capable of controlling 
behavior (T. E. Robinson and Berridge 1993), (Uslaner et al. 2006).  Reward involves 
both ‘liking,’ the pleasure involved in experiencing the hedonic effects of reward, and 
‘wanting,’ the motivation to pursue a reward (Berridge 2007).  Incentive salience 
accounts for the ‘wanting’ component of reward; incentive stimuli are attractive, can 
reinforce drug seeking, and are capable of increasing motivation to seek drugs, i.e., 
affecting drug ‘wanting’ (Milton and Everitt 2010), (Saunders and Robinson 2010).   
Under the assumption of the incentive sensitization theory, goal-tracking rats 
learn to predict an impending reward when the lever is extended; sign tracking rats also 
learn to predict a reward stimulus with the lever, but importantly, the lever also becomes 
salient and attractive to a Sign Tracker.  Rats who display sign-tracking behavior may 
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have an underlying susceptibility to attribute incentive salience to a Conditioned Stimulus 
(Terry E. Robinson et al. 2014), which when paired with learned associations may lead to 
addictive behavior (Berridge 2007), (T. E. Robinson and Berridge 1993). 
 
Neural Representations of Sign Tracking 
 
The incentive value of a stimulus is necessary for increased activity in brain 
structures involved in processing reward, which are part of the mesolimbic dopamine 
system (explained in further detail below), including the Nucleus Accumbens (NAc) 
(Flagel et al. 2011).  The NAc is also involved in developing cue-directed behavior for 
Pavlovian conditioned approach (Day et al. 2006).  Neurons in the Ventral Pallidum 
(VP), another reward structure, respond to both the CS and the UCS, showing the area’s 
involvement in both the hedonic ‘liking’ and motivational ‘wanting’ of reward (Tindell, 
Berridge, and Aldridge 2004).   
The differing rat behaviors in PCA experiments are accompanied by different 
neural firing patterns in the mesolimbic dopamine circuit during cue presentation, which 
has been shown by behavioral analysis and in vivo electrophysiological recordings.  Sign 
Trackers exhibit sustained firing in the Ventral Pallidum in the presence of the CS 
(Ahrens et al. 2016), as well as increased dopaminergic firing in Nucleus Accumbens 
(NAc) when presented with the CS alone (Flagel et al. 2011).  The neurotransmission in 
Sign Trackers in the presence of a reward cue is similar to the effects of 
pharmacologically activating mesolimbic dopamine structures to increase incentive 
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salience (Tindell et al. 2005).  This heightened responsiveness to reward-predicting cues 
has consequences; Sign Trackers undergo reinstatement of drug use more often than goal-
tracking rats (Saunders and Robinson 2011), (Tomie, Grimes, and Pohorecky 2008), 
(Flagel, Akil, and Robinson 2009), (Yager and Robinson 2013).  Other indications that 
sign tracking is a marker for susceptibility to drug addiction are experiments showing that 
STs choose cocaine over food more often than GTs (Tunstall and Kearns 2015), and that 
STs will work harder (will nose poke more) for cocaine compared to GTs (Saunders and 
Robinson 2011).     
In order to better understand the neural basis for behavior that may predispose a 
rat to addiction, the brain structures known to be involved in both components of reward 
should be investigated.  Altered cell firing in reward processing brain areas, or in a 
specific neural pathway, may result in changed behavior toward conditioned stimuli. 
 
Mesolimbic Dopamine 
 
Dopaminergic transmission in the brain has various functions, depending on the 
structures being observed and the complex integration of other neural inputs (Wightman 
and Robinson 2002).  Dopamine (DA) signaling is known to be involved in reward 
prediction error, a form of coding reward value in order to promote adaptive behavior 
(Schultz, Dayan, and Montague 1997), (Tobler, Fiorillo, and Schultz 2005).  Ongoing 
attempts to understand its role in motivation are currently underway, as dopamine 
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transmission is involved in the pathological and physiological consequences of drug 
abuse (Cohen et al. 2012).   
The mesolimbic dopamine circuit (shown in Figure 2), includes the Ventral 
Tegmental Area (VTA), which receives input from the Ventral Pallidum and sends 
dopaminergic neurons to the Nucleus Accumbens (Haber, Fudge, and McFarland 2000).  
The VTA is involved in ‘wanting’ drugs (Dichter, Damiano, and Allen 2012).  Dopamine 
release takes place in the NAc during reward, as well as in response to a cue when a rat 
learns the cue-reward association (Stuber et al. 2008). 
Previous studies have shown that drugs of abuse increase dopamine 
neurotransmission in the mesolimbic dopamine system (Di Chiara and Imperato 1988) 
and that repetitive use of addictive drugs can cause drug-evoked synaptic plasticity 
(Lüscher and Malenka 2011), (Bocklisch et al. 2013), (Brown et al. 2010).  The increased 
excitability of mesolimbic DA synapses after drug use has been shown by measuring 
postsynaptic responses to drugs preceding and following prolonged drug use (Lüscher 
and Malenka 2011).  For instance, excitatory afferents that synapse onto DA neurons in 
the VTA become stronger following the circuit remodeling that occurs with drug use 
(Brown et al. 2010).  Additionally, these effects can be long lasting.  An experiment has 
shown that Self-Administration of cocaine can alter the ratio of receptors on neurons in 
the VTA, making them more excitatory, and that these changes persist even after drug 
extinction (Chen et al. 2008).  Looking at specific neural pathways in the reward circuit is 
the focus of ongoing research.  Isolating components of the reward circuit involved in 
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cue-related, i.e., reinforced behavior may help with understanding the maladaptation that 
occurs in addiction. 
 
Figure 2 – Mesolimbic Dopamine Projections in the Brain: Shown in orange are 
dopamine neurons going from the Ventral Tegmental Area (VTA) to the Nucleus 
Accumbens (NAcc).  Shown in red are GABA projections going to the Ventral Pallidum 
(VP) from the NAcc, and then from the VP to the VTA. Reference: (Dichter, Damiano, 
and Allen 2012). 
 
The Ventral Pallidum 
 
The Ventral Pallidum is involved in many forms of motor behavior, including 
behavior involved in reward motivation (Root et al. 2015) and is made up of primarily 
GABA (gamma-Aminobutyric Acid) generating neurons (Root et al. 2015).  The Ventral 
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Pallidum is necessary for learning Pavlovian associations and developing conditioned 
preferences (Chang et al. 2015).  For example, if a rat is repeatedly exposed to an 
environment that is paired with a drug, it may prefer that environment in instances 
without the drug even being present, compared to another environment without the 
conditioned place preference.  Lesions in the VP prevent the acquisition of conditioned 
place preference, even when subjects remain interested in obtaining a sucrose reward 
(McAlonan, Robbins, and Everitt 1993), (Smith et al. 2009).  VP neurons are excited by 
cues signaling reward (Smith, Berridge, and Aldridge 2011), (Tindell et al. 2005) and 
play a role in translating cue responses into reward-seeking behavior (Richard et al. 
2016), (Waraczynski and Demco 2006).   
The VP is one of the main projection sites to the VTA (Faget et al. 2016), with 
VP GABA neurons influencing VTA neural firing rates (Hjelmstad et al. 2013).  The VP 
to VTA pathway is of particular interest to this study because it is a specific pathway 
involved in drug ‘wanting’ (Berridge 2007).  Studies have shown that the rostral VP 
projections to the VTA are activated during cue-induced reinstatement of cocaine seeking 
and that use of inhibitory DREADDs in the rostral VP caused decreased amounts of cue-
induced drug reinstatement (Mahler and Aston-Jones 2012), (Mahler et al. 2014).  
However, studies have also showed that disinhibition (removal of inhibition) of the VTA, 
either directly with GABAA receptor agonists activating local inhibitory interneurons, or 
indirectly through inhibiting VP input to the VTA, can cause an increase in cue-instated 
cocaine seeking and increased lever pressing for drugs (Mahler et al. 2014), (Leung and 
Balleine 2015).  Since VP inputs influence the overall firing rate of DA neurons in the 
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VTA and activation of GABAergic cells leaving the VP causes inhibition of the VTA 
(Hjelmstad et al. 2013), inhibition of VP inputs to the VTA may cause an overall increase 
in DA firing in the VTA through the process of disinhibition.  This study will aim to 
cause the above-mentioned disinhibition process in the VTA, by means of new chemo-
genetic tools. 
 
 
Designer Receptors Exclusively Activated by Designer Drugs, Tools for 
Manipulation 
 
A method to alter neural firing exists where a viral vector is used to deliver 
genetic material to a location of interest; the vector induces target neurons to synthesize 
G-protein coupled receptors (Roth 2016).  These designer receptors are not activated by 
endogenous ligands (Whissell, Tohyama, and Martin 2016).  Instead, the receptors may 
be activated advantageously during in vivo behavioral testing by injecting a synthetic 
ligand.  The receptor activation, which occurs through G-protein coupled signaling, can 
be exploited to enhance or dampen particular neuronal connections, depending on the 
type of agent used (Roth 2016).  These engineered receptors are termed Designer 
Receptors Exclusively Activated by Designer Drugs (DREADDs).  There are currently 
activating and inhibiting DREADDs being used in in vivo studies that act through altering 
G-protein coupled signaling (Roth 2016).  With the ability to activate DREADDs during 
experimentation via systemic injection of a DREADD agonist such as Clozapine-N-
Oxide (CNO), which is biologically inactive in rats, it’s possible to experimentally effect 
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neural activity and behavior through selective alteration of particular neurons (Mahler et 
al. 2014), (Guettier et al. 2009).   
In addition to targeting cells in a specific brain area, specific projections of 
neurons can be targeted for DREADD expression by using a FLEX-switch DREADD 
virus, which has an inverse orientation that prevents expression of the DREADDs until 
the viral vector interacts with Cre-recombinase (Cre) (Urban and Roth 2015).  By 
injecting Canine Adenovirus (CAV)-Cre-recombinase into axonal projections of interest, 
which will travel retrogradely to reach the cell bodies containing the FLEX-switch 
DREADD virus, one can target neurons based on their cell body and terminal locations 
(Urban and Roth 2015), (Boender et al. 2014).  This Cre-dependent expression of 
DREADDs enables the targeting of a neural pathway in order to better understand the 
relationship between interacting brain areas. 
In a previous study, inhibitory DREADDs placed in the rostral Ventral Pallidum 
altered the pathway going from the VP to the VTA (Mahler et al. 2014).  How these 
neuronal firing changes would exhibit themselves in rats participating in Pavlovian 
Conditioned Approach sessions is an opportunity for further study. 
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SPECIFIC AIMS 
 
  
The present study was designed to manipulate Ventral Pallidum firing patterns, in 
vivo, in Sign Trackers, Goal Trackers and Intermediates with the aim of affecting 
downstream neuronal activity, which may result in altered processing of the ‘wanting’ 
component of reward.  The impact this manipulation of reward circuitry may have on 
Pavlovian Conditioned Approach behavior is of interest, specifically, the behavior during 
the period following cue presentation and preceding response-independent food pellet 
reward.  Since this period of time differentiates the behavioral tendencies of rats, changes 
in rat behavior under this experimental paradigm would contribute to evidence showing 
these behavioral tendencies are plastic and subject to manipulation.   
To alter neuronal firing, DREADD technology will be utilized.  Neurons in the 
Ventral Pallidum will be targeted and will receive inhibitory DREADDs.  This study will 
inhibit a specific pathway – the GABAergic neurons that project from the Ventral 
Pallidum to the Ventral Tegmental Area – in order to determine if altering the Ventral 
Pallidum’s normal regulation on the VTA will in turn affect VTA output and impact the 
amount of dopamine in the mesolimbic circuit.  Based on prior studies that investigated 
the effects of inhibiting the Ventral Pallidum, disinhibition, i.e., increased firing, of 
Ventral Tegmental neurons is expected to occur.  The goal of manipulating this circuit is 
to alter the incentive value of a reward cue without changing its predictive value. 
 The hypothesis of this study is that inhibition of the GABAergic neurons from the 
Ventral Pallidum that synapse onto the Ventral Tegmental Area will cause the incentive 
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properties of the cue predicting reward, the lever, to be strengthened, making rats more 
sensitized to it and more likely to interact with it.  If this hypothesis proves to be correct, 
rat behavior will shift towards sign tracking in non-sign tracking phenotypes (Goal 
Trackers and Intermediates) and sign tracking rats may also become more engaged with 
the lever, compared their baseline levels.  The goal of this study is to observe increased 
lever interaction across all rat phenotypes in PCA sessions where the DREADDs are 
activated with a CNO injection. 
This study strives to illuminate which neural pathways are involved in the 
tendency to attribute incentive salience to cues that predict reward.  Altering rat behavior 
in this study will show that a specific neural pathway may be involved in predisposing 
rats to addiction and may aid in the development of translational therapies for drug 
addiction.   
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METHODS 
 
Ethics Statement: 
 
All animal work was conducted according to guidelines approved by the 
University of Michigan Committee on the Use and Care of Animals (UCUCA) and 
Institutional Animal Care and Use Committee (IACUC).  
 
Animals and Care: 
 
Sixteen male Sprague Dawley rats with initial weights of 200-250g (Charles 
River, Wilmington, MA) were housed in pairs on a reversed light-dark (14-10) cycle with 
lights off at 10:00 A.M.  The subjects had 2 days to habituate to their new surroundings 
after being delivered.  Under housing conditions, water and food were supplied ad 
libitum (no restrictions).  All subjects underwent surgery for implantation of viral vectors 
encoding DREADDs.  For two days following surgery, rats were given intra-peritoneal 
injections of Penicillin (0.1 mL) and Flunixin (2.5 mg/kg) to prevent infection and 
provide pain relief, respectively.  Subjects were given 1 week to recover from surgery, 
and then another 2 weeks of sitting (non-testing period) to ensure viral expression was 
present before the testing period began. Rats were handled daily for 7-10 days before 
Pavlovian Conditioned Approach (PCA) training.  All testing was performed during the 
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dark cycle, between 10:00-18:00 so that no behavioral changes would be due to circadian 
rhythm disruptions.  For a timeline of the entire testing period, see Figure 4 (below). 
 
 
Figure 4 – Experimental Timeline: Timeline for each of four rat waves. 
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Implantation of Viral Vectors: 
 
Animals were anesthetized with 2% Isoflurane/1% Oxygen and their heads were 
secured to a Kopf Stereotax. The surgical site was sterilized following hair removal from 
the top of the skull.  A local analgesic was then injected subcutaneously at the surgical 
site for pain relief. A 2-inch incision was made in a Rostral-Caudal direction to expose 
the skull.  The suture lines Bregma and Lambda were used as landmarks; once they were 
identified, the stereotaxic apparatus, a three-dimensional coordinate system, was used to 
ensure the Dorsal-Ventral (DV) measurements of the sutures were within 10 µm apart, 
demonstrating that the head was level.  Calculations were used in combination with the 
stereotaxic system so that the implantation sites could be mapped out.  A 1 mm bilateral 
craniotomy was created over the rostral VP at the following stereotaxic locations: 
Anterior-Posterior (AP): +0.42, Medial-Lateral (ML): +/- 1.7, Dorsal-Ventral (DV): 8.0.  
A 1 mm bilateral craniotomy was also created over the VTA at AP: -5.1, ML: +/- 1.0, 
DV: 7.0.  
A dual vector approach was utilized in order to specifically target neurons that 
project from the VP to the VTA using Designer Receptors Exclusively Activated by 
Designer Drugs (DREADDs).  FLEX-switch inhibitory DREADDs were injected, using 
Hamilton Syringes, into the VP and taken up by cell bodies, while retrogradely 
transported Canine Adenovirus Cre-recombinase (CAV-Cre) was injected into the VTA.  
The dual vector approach ensures that only those cells that take up both DREADDs and 
CAV-Cre viruses express the inhibitory designer receptors.  Viruses were injected 
slowly, at a rate of 0.2 µL/min, using an electronic pump and afterwards the syringes 
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were left in their implantation locations for 15 min, in order for any residual virus in the 
syringes to diffuse out.  Wounds were closed with a continuous suture method, using silk 
sutures.  
 
PCA Chambers and Training Sessions: 
 
PCA training was carried out in order to group rats into different behavioral 
phenotypes.  In a PCA session, animals are placed in a metal and Plexiglass testing 
chamber (30.5 x 24.1 x 21 cm; Med Associates).  The chambers are located in cabinets to 
attenuate sound; they also contain a house light and white noise speaker on one wall. 
Opposite to the wall containing the house light is a magazine for food delivery, located in 
the center of the wall, approximately 1 cm from the floor. To the left of the magazine is 
an LED retractable lever, about 6cm from the floor.  Each session begins with 
illumination of house light and white noise. 
This study used four waves of animals, each containing four rats.  Sixteen animals 
in total underwent five days of PCA training 3 weeks after their DREADD implantations, 
the duration of time deemed necessary by previous experiments in this laboratory.  
Before training sessions began, rats were given banana-flavored sucrose pellets in their 
home cages (45 mg of banana-flavored food pellets; BioServ, Frenchtown, NJ) in order 
to familiarize them with the reward they would be presented with during PCA sessions.   
The following day, all rats were given an initial 25-trial pretraining session, where 
banana pellets (UCS) were delivered to the magazine on a variable time-30 schedule 
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(average 30 seconds, range 15-45 seconds), in order to become familiar with the delivery 
of the banana pellets into the magazine.  On the PCA training days, rats underwent a 
single PCA session consisting of 25 trials.  Each Pavlovian trial began with presentation 
of the illuminated lever (CS), which inserts through the wall into the chamber for 8 
seconds before retracting.  A banana pellet reward (UCS) is released at the moment the 
lever retracts (the lever’s LED light also turns off) and is delivered into the magazine 
600msec later.  Trials were separated by variable time intervals with an average of 90 
seconds and a range of 30-150 seconds (See Figure 3).  Animals were returned to their 
home cages following each training session.  
 
 
Figure 3 – PCA Trial: Layout of the trial period and inter-trial period in a PCA session. 
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PCA Indexing: 
 
Previous reports have indicated that quantification of PCA behavior is possible by 
calculating a PCA Index Score, which corresponds to one of three different rat behavioral 
phenotypes and importantly predicts the tendency to attribute incentive salience to a cue 
predicting reward (Meyer et al. 2012).  It is also reliable with low sample sizes (Meyer et 
al. 2012).  The PCA Indexing is performed based on behavioral data from days 4 and 5 of 
PCA training, as studies have shown behavioral phenotypes become apparent and stable 
by the 4th and 5th days of training.  
The PCA Index is determined by looking at three factors.  The latency score 
accounts for the time it takes for a rat to interact with the lever or enter the magazine 
during CS presentation.  The response bias measure reflects bias towards the lever or the 
magazine.  Finally, the probability difference measure compares the probability of 
contacting the lever to the probability of entering the magazine.  The probability of 
contacting the lever or entering the magazine are defined as the number of trials with 
lever contact or magazine entry, divided by the total number of trials.  Lever contact and 
lever press are interchangeable in this experiment, both referring to a lever deflection 
occurring.  Rats need to apply an adequate amount of pressure onto the lever in order for 
it to be counted as a lever press/lever contact in the data collection process.  Table 1 
contains full calculations for obtaining each of these three factors, as well as the final 
PCA Index Score.  A final PCA Index Score of less than -0.5 indicates a GT phenotype; a 
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score of greater than +0.5 indicates a ST phenotype, and a score ranging from -0.5 to 
+0.5 corresponds to an Intermediate phenotype.  
 
Deriving the PCA Index Score 
Response Bias = (Lever Presses – Mag Entries)/(Lever Presses + Food Cup Entries) 
Probability Difference = p|Lever Press – p|Mag Entry 
Latency Score = (x̅ Mag Entry Latency - x̅ Lever Press Latency)/8 
PCA Score (n) = [Response Bias(n) + Latency Score(n) + Probability Difference(n)]/3 
PCA Index Score = [PCA Score(4) + PCA Score(5)]/2 
 
(n) = any particular test session 
x̅ = averaged Latency 
p| = probability 
 
Notes: The last days of PCA training, days 4 and 5, were observed to calculate a PCA 
score for each respective day.  The PCA scores for day 4 and day 5 were averaged to 
give each rat a PCA Index Score.  The latency score was the averaged difference 
between magazine entry latency and lever contact latency, divided by the length of the 
CS duration, 8 seconds. 
 
Table 1: Deriving the PCA Index Score.  Reference: (Meyer et al. 2012) 
 
 
PCA Testing Sessions: 
 
After their PCA training, animals were deemed STs, GTs or INTs.  At this point 
in the experimental process, the VP neurons of interest in the rats contained DREADD 
expression and were targeted in vivo, in between PCA sessions, by a systemic injection of 
an otherwise inert drug, Clozapine-N-Oxide (CNO).  The day after their training was 
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finished, subjects went through ten additional days of testing.  Each of these testing days 
consisted of 2 PCA sessions per day, with an injection of either saline (during the first 
five days) or CNO (during days 6-10) made after the first PCA session and preceding the 
second PCA session.  The CNO injection amount was 3.0mg/kg and was an intra-
peritoneal injection.  The saline injection was through the same route and was the same 
amount as the CNO injection, calculated from each rat’s weight before the ten-day testing 
period.  During each PCA session, data collection took place through Med Associates 
software, which recorded the latency to lever press, latency to magazine entry, total 
number of lever presses, and total number of magazine entries for every trial.  
Following a systemic injection of CNO, the drug peaks in the bloodstream within 
30 minutes and is cleared from the plasma two hours later (Guettier et al. 2009).  For this 
reason, PCA index scores in both CNO and saline sessions were calculated as outlined 
above, but while looking at a subset of a full PCA session.  Since each PCA session takes 
approximately 45 minutes, the last 10 trials of the testing sessions (pre and post 
treatment/injection) were used.  This was a way to analyze the behavioral changes that 
occur as a result of CNO-driven DREADD activation while excluding trials without a 
DREADD effect. 
 
Behavioral Analysis/Statistics: 
 
After the PCA index scores were calculated using the method outlined in Table 1, 
one-way ANOVA analysis assessed differences between the three rat phenotypes. 
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In case any drug levels reached the DREADDs more quickly than anticipated, an 
analysis of behavior during each PCA session, in 5-trial blocks, was carried out for the 
first day of testing with saline and CNO.  Behavioral changes within the PCA sessions 
were analyzed in 5-trial blocks for the probability to approach the lever or magazine, the 
latency to lever press or enter the magazine, and the average lever contacts and magazine 
entries per trial.  Comparison of pre to post treatment values, i.e., the PCA session before 
either a saline or CNO injection compared to the saline or CNO-affected PCA session, 
was carried out, along with comparison of saline trials to CNO trials, in order to 
determine when CNO exerts its effects on DREADDs.  Paired t-tests, carried out with 
GraphPad Prism (Version 6), were performed to compare the saline and CNO means for 
the behavioral factors mentioned above throughout PCA sessions.  
To analyze the main effect of CNO-activated DREADDs, changes in PCA Index, 
and other behavioral variables, were calculated by subtracting pre-treatment values from 
post-treatment values each testing day.  This created a difference score for every saline 
testing day and every CNO testing day.  Statistical analyses were performed with SPSS 
(Version 24) to explore the probability to approach lever or magazine, the latency to lever 
press or enter the magazine, and the average lever contacts and magazine entries per trial.  
Difference scores were analyzed with two-way (treatment x time) Repeated Measures 
ANOVAs, with both treatment (CNO or saline) and time (testing day) as within-subjects 
factors. If the assumption of sphericity was violated, Huynh-Feldt corrected degrees of 
freedom and p values are reported.  
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Finally, changes in the PCA Index that occurred over time in each rat were 
analyzed by comparing the PCA Index Scores on the first and last day of testing (Day 1 
and Day 5) for both saline and CNO testing periods.  Linear regression with analysis of 
the difference in slopes, using GraphPad Prism (Version 6), was performed to determine 
if changes in PCA behavior over time were more pronounced in CNO compared to saline 
sessions.  Statistical significance was set at p < 0.5. 
 
Histology: 
 
Rats were deeply anesthetized with an overdose of Pentobarbital and then 
perfused transcardially with saline followed by 4% Paraformaldehyde.  Brains were 
removed then stored in Paraformaldehyde for 24 hours before being stored in 30% 
sucrose solution. Brains were sliced coronally, in 40 μm sections, and stored in 
cryoprotectant until slicing. Brain slices containing the rostral VP were taken and were 
mounted onto glass slides for observation under the microscope. DREADDs contain a 
(mCherry) tag that naturally fluoresces between 587-610 nm.  DREADD expression in 
the Ventral Pallidum was confirmed using a fluorescent microscope with help from the 
Paxinos and Watson Brain Atlas (1997) to assess the location of the virus implantation. 
DREADD expression confirmation in brain tissue was necessary for the accurate 
assessment of the effect of CNO injections on PCA behavior.  Behavioral analysis was 
only performed in animals with confirmed DREADD expression in the rostral VP. 
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RESULTS 
 
Examination of Three PCA Phenotypes 
 
In past studies, PCA indexing has showed a broad, bimodal distribution of Sign 
Trackers, Goal Trackers and Intermediates (Meyer et al. 2012).  In our analysis of 14 rats 
(2 out of the 16 trained rats couldn’t be confirmed for DREADD expression), 6 of them 
were Sign Trackers, 5 were Goal Trackers and 3 were Intermediates, displayed in Figure 
5.  These three phenotypes have statistically significant (p value < 0.0001) PCA Index 
Scores, as shown in Figure 6.  To identify DREADD induced changes in phenotype 
behavior during the 8 second PCA trial, we compared behavior indices before and after 
CNO administration. 
Compared to the other two phenotypes, Sign Trackers (STs) were characterized 
by high numbers (Figure 7) and high probabilities of lever contacts.  STs also had lower 
levels of magazine entries during trials (Figure 8), and a lower probability of entering the 
magazine while the lever is extended.  The latency to lever contact is shorter in STs, 
meaning they are quick to approach and contact the lever when it’s presented (Figure 9).  
The latency to enter the magazine, on the other hand, is longer in Sign Trackers, as they 
typically wait until the 8 seconds of the trial are over before retreating to the magazine for 
the reward.  The sign-tracking group of rats had a mean PCA Index Score of +0.72, a 
mean of 74 lever presses per PCA session, an 89% chance of lever contact per trial on 
average, and a mean lever latency of 3.92 seconds.  They additionally had an average of 3 
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magazine entries per session, only a 10% chance of magazine entry during a trial, on 
average, and an average magazine latency of 7.3 seconds. 
A Goal Tracker is in every aspect being examined the opposite of a Sign Tracker.  
Fewer lever contacts (Figure 7), along with high numbers of magazine entries (Figure 8), 
distinguish them during lever presentation.  The Goal Trackers, as a group, had an 
average PCA Index Score of -0.82, a mean of 82 magazine entries per session, a 90% 
chance of magazine entry per trial on average, and a mean latency to enter the magazine 
of 2.8 seconds.  They also had low levels of lever contact (1.1 presses per session) on 
average, along with a 3% average probability of lever contact per trial and a high average 
latency to contact the lever, at 7.9 seconds (Figure 9). 
Intermediate animals show characteristics that lie between Sign Trackers and 
Goal Trackers (Figure 6).  They have a high probability of contacting both the lever and 
the magazine and have an intermediate lever latency (Figure 9) and magazine latency 
compared to the other two phenotypes.  The intermediate rats had an average PCA Index 
Score of +0.04, an average of 35 lever presses and 39 magazine entries per session, a 
mean probability of lever contact of 69% and a 64% mean probability of magazine entry.  
They had similar mean latencies to lever contact and magazine entry, at 4.92 seconds and 
5.2 seconds, respectively.  Based on the expectation that all animals were hypothesized to 
show more sign-tracking characteristics with DREADD activation, we grouped 
Intermediates with Goal Trackers for analysis, creating a non-ST group, and contrasted 
those findings to observations in Sign Trackers.  This is a conservative combination as 
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Intermediates have characteristics closer to Sign Trackers and combining them with Goal 
Trackers only diminishes the group average impact of changes toward Sign Tracking. 
 
 
Figure 5 – Distribution of Phenotypes: This study looks at 14 rats in total: 6 
Sign Trackers, 5 Goal Trackers and 3 Intermediates. 
   
 
****
 
Figure 6 – PCA Index Score: PCA Index Scores for 14 rats undergoing analysis.  
Rats were grouped into one of three phenotypes, which all differed from each 
other significantly, ****p < 0.0001. 
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Figure 7 – Lever Contacts: Mean lever contacts during cue presentation in a 
PCA session for each phenotype, ***p < 0.001, *p < 0.05. 
 
 
****
*
*
 
 
Figure 8 – Magazine Entries: Mean magazine entries during cue presentation in 
a PCA session for each phenotype, ****p < 0.0001, *p < 0.05. 
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Figure 9 – Lever Latency: Mean latency to contact the lever during cue 
presentation in a PCA session for each phenotype, ****p < 0.0001, **p < 0.01. 
 
 
 
Analysis of a Single PCA Session in Five-Trial Blocks 
 
The first day of testing with either a saline or CNO injection was analyzed in 
detail in order to observe when CNO-activated DREADDs present behavioral changes 
after a systemic CNO injection.  Both the CNO and saline testing days consisted of two 
back-to-back PCA sessions, one pre-injection and one post-injection, with either saline or 
CNO administration preceding the second session of the day.  Each PCA session of the 
day was broken up into 5-trial blocks: Trials 1-5, 6-10, 11-15, 16-20 and 21-25.  Figures 
10 and 11 display these results, with Baseline data points corresponding to the values 
from the first PCA session that took place on a particular testing day (pre-injection).  The 
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data points in the “Treatment” section of these graphs are from the second PCA session 
of the day, after either systemic saline or CNO administration (post-injection).   
The greatest trend seen from day one analysis was a steady decrease in lever 
contacts per trial throughout both baseline PCA sessions, followed by steady amounts of 
lever contacts in the saline PCA session.  There was a significant increase in the average 
lever contacts per trial, in trial blocks 2 and 5 (Figure 10), in the CNO session compared 
to saline (p value = 0.0058).  This result was only observed in Sign Trackers.  Lever 
probability among Sign Trackers showed a similar trend, with the average probability of 
lever contact decreasing toward the end of both baseline PCA sessions, as well as during 
the saline session, and increasing the in the CNO session, though this was not statistically 
significant.  Changes in lever latency within the sign tracking group also failed to reach 
significance, but the average latency to contact the lever increased through successive 
trial blocks in baseline sessions and the saline session while it decreased in the CNO 
session, going from approximately five seconds in the first five trials to four seconds in 
the last five trials (shown in Figure 11).  
It is worth noting that the starting lever contact measure in both treatment PCA 
sessions is lower than the amount at the beginning in the baseline PCA sessions.  What 
was evident is that this diminished amount of lever pressing stayed constant in the saline 
session while it increased in the CNO session (Figure 10).  The observation that the 
second PCA session of the day starts with fewer lever contacts suggests that rats may 
become slightly fatigued and/or satiated at the end of a normal PCA session.  This has 
been observed in PCA training, though only to slight degrees that do not change overall 
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behavioral phenotypes for a session.  CNO appears to be reinvigorating a Sign Tracker’s 
lever pressing response, as the measure to lever press is rising in the CNO session 
compared to saline.  This trend is shown in lever latency (Figure 11), with the starting 
latency to lever press in both treatment sessions being higher than the baseline levels.  
Only in the CNO session does the lever latency begin to drop toward its starting value in 
the PCA baseline session in the 5th trial block. 
No significant changes took place among the Goal Tracker/Intermediate group of 
rats and there were also no noticeable trends taking place.  Additionally, all activity 
related to the magazine, including probability of entry, latency to enter and total 
magazine entries, remained stable throughout baseline sessions as well as the saline and 
CNO sessions.   
Though the effects of CNO-activated DREADDs were not as pronounced as 
anticipated, they appeared to take place in the 2nd trial block, but also later in the PCA 
session, during the last two trial blocks.  For the next step of analysis, looking at the last 
10 trials will be suitable for comparing trials with a CNO effect to control (saline) trials. 
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Figure 10 – Trial Blocks Showing Lever Contacts in Sign Trackers: Baseline 
= pre-injection data while Treatment = post-injection data. Only the data in the 
Treatment section of this graph have the influence of either Saline or CNO, since 
rats received injections after the PCA sessions whose data are plotted in the 
Baseline section of this graph.  Among Sign Trackers, in the Treatment (post-
injection) analysis, the average lever contacts per trial increased throughout the 
CNO session compared to the saline session, **p < 0.01.   
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Figure 11 – Trial Blocks Showing Lever Latency in Sign Trackers: An overall 
trend of an increase in lever latency during Baseline (pre-injection) sessions is 
shown in Sign Trackers.  There is also a slight decrease in lever latency with CNO 
compared to saline in STs in the Treatment (post-injection) section of this graph. 
 
 
 
The Impact of CNO vs. Saline on PCA Behavior 
 
The difference between each CNO or saline session and their corresponding 
baseline PCA sessions was analyzed.  Baseline behavior was subtracted from treatment 
behavior in order to make a difference score.  This is a way to look at how CNO changes 
PCA behavior on a given day compared to saline.  A large value for a difference score 
indicates that there was a significant difference between behavior during the baseline and 
treatment session.  The sign of the difference score must be taken into account for each 
behavioral measure.  For instance, if lever contacts increase from a baseline PCA session 
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to a CNO session, a positive difference score will appear for that day, an indication of 
more sign tracking.  However, if lever latency decreases from a baseline PCA session to a 
CNO session, a negative difference score will result, which is also an indication of more 
sign tracking.  The difference scores between the baseline PCA and saline session are 
expected to be near zero. Difference scores were analyzed using a repeated measures 
two-way (treatment x time) ANOVA.  A significant effect of treatment was predicted, 
with CNO difference scores expected to be more prominent than saline difference scores. 
Among Sign Trackers, the saline difference scores for lever contacts stayed close 
to zero for the most part, with the exception of day two (Figure 12).  Day one has a 
difference score of close to 1 (0.788) indicating that the sign trackers in the post-CNO 
session had on average 1 additional lever press per trial.  Although the CNO difference 
score is higher than the saline difference score on day two, it is still close to zero.  The 
saline difference score on day two is due to the saline (post-injection) session having a 
low number of lever contacts compared to the earlier baseline (pre-injection) session that 
day and therefore the relatively higher CNO value isn’t viewed as significant.  There was 
no significant main effect of treatment for lever contacts in Sign Trackers.  Significant 
effects of time, where difference scores would vary based on the testing day, were not 
expected.  Yet, there seems to be a trend, though not significant, showing a larger 
difference score on day one of testing with CNO compared to the remaining testing days, 
with the saline and CNO difference score values matching at day five.     
There was a significant main effect of treatment for lever latency in Sign Trackers 
(F(1, 5) =7.04, p < 0.05).  Figure 13 shows that the saline difference scores, as expected, 
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were near zero for all but one testing day.  The CNO difference scores in comparison are 
slightly negative, showing that on average, sign trackers are approaching the lever more 
quickly in CNO sessions compared to saline sessions, by approximately 30 seconds (day 
one) to one minute (day four).  The saline difference score for day two is also unusual for 
lever latency, as it was for lever contacts; its large, positive value makes the CNO 
difference score far apart from it, yet still close to zero. 
There were no significant effects of treatment in the GT/INT group, nor were 
there observed trends in behavior among that group.  No significant effects of treatment x 
time were observed in either rat group. 
 
Figure 12 – CNO vs. Saline Difference Score – Lever Contacts in Sign 
Trackers: CNO values correspond to CNO – PCA difference scores for each day 
(session).  SAL values correspond to SAL – PCA difference scores for each day.  
A positive difference score for lever contacts corresponds to increased ST 
behavior. 
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Figure 13 – CNO vs. Saline Difference Score – Lever Latency in Sign 
Trackers – CNO values correspond to CNO – PCA difference scores for each 
day (session).  SAL values correspond to SAL – PCA difference scores for each 
day.  Two-way ANOVA analysis for days 1-5 showed significant differences in 
latency to contact the lever among Sign Trackers, *p < 0.05.  A negative 
difference score for lever latency corresponds to increased ST behavior. 
 
 
 
Behavioral Effects of DREADDs Over a Five Day Span of Testing 
 
Looking at changes within a session and across saline and CNO sessions did not 
reveal any significant changes in PCA behavior in the Goal Tracker/Intermediate group, 
yet some trends and significant results were presented in Sign Trackers.  The last step in 
analysis was to observe if any subtle changes in behavior occurred throughout the five-
day span of testing for either saline or CNO.  In order to control for the transient effects 
of CNO on behavior, only the baseline PCA sessions were used to look at behavioral 
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measures over five testing days.  Full sessions were used to observe changes in 
behavioral measures in a session (not per trial).  This interestingly revealed shifts in 
behavior towards sign tracking in the GT/INT group. 
When looking at the overall PCA Index Score, the average value for the combined 
Goal Tracker and Intermediate group increased slightly when going from day one to day 
five of testing with saline (Figure 14), though the slope did not significantly deviate from 
zero.  The PCA Index Score during the five-day CNO testing span increased steadily on a 
daily basis (Figure 15), with a significantly non-zero slope (R square = 0.9827, Slope = 
0.08672, p value = 0.001).  The PCA Index Scores on CNO testing day one take off from 
their ending values on saline testing day five, starting off lower in the CNO testing span 
compared to the saline span. 
The average magazine entries per trial decrease only slightly during saline testing 
(Figure 16) while decreasing by about a third during the CNO testing week, from 61 to 
42, shown in Figure 17.  The magazine entries during CNO testing has a significantly 
non-zero slope (R square = 0.9837, Slope = -4.475, p value = 0.0009).  A similar event is 
shown in Figures 16 and 17 as in the PCA Index Score graphs, where the slight changes 
that took place during the saline week are starting points that changed more drastically 
during CNO testing. 
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Figure 14 – Five Testing Days with Saline – PCA Index Changes: The 
baseline PCA Index values show a slight upward trend, but no significant 
deviation from zero in the slope. Each data point is an average from all rats in the 
GT/INT group for a particular day. 
 
 
 
Figure 15 – Five Testing Days with CNO – PCA Index Changes: The baseline 
PCA Index values show an upward trend towards a Sign Tracking PCA Index 
with a slope at approximately -0.1. Each data point is an average from all rats in 
the GT/INT group for a particular day. 
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Figure 16 – Five Testing Days with Saline – Magazine Entry Changes: The 
baseline magazine entry values show a slight downward trend, but no significant 
deviation from zero in the slope. Each data point is an average from all rats in the 
GT/INT group for a particular day. 
 
 
Figure 17 – Five Testing Days with CNO – Magazine Entry Changes: The 
baseline magazine entry values show a downward trend with a slope at 
approximately -4.5. Each data point is an average from all rats in the GT/INT 
group for a particular day. 
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Confirmation of DREADD Expression with mCherry Fluorescence 
 
 
 
Figure 18 – The Ventral Pallidum: A rat brain atlas image (Paxinos and Watson, 1997) 
outlining the Ventral Pallidum’s location (left) is shown next to a coronal brain slice 
under fluorescent (TXRED) microscope (right).  The fluorescent image (right) was taken 
from the right hemisphere of a rat brain and mounted onto a glass slide, which reversed 
its orientation.  The atlas and fluorescent images are superimposable for the purpose of 
outlining the Ventral Pallidum on both sides of the brain.  The location of interest (VP) is 
circled in yellow.  Although DREADDs cannot be seen easily at this magnification (5X), 
the figure below (Figure 19) shows a more magnified version of the encircled area in the 
fluorescent brain slice above.  Reference: Paxinos and Watson (1997).  
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Figure 19 – DREADDs in the Ventral Pallidum: A zoomed-in version of the encircled 
region in Figure 18, in the Ventral Pallidum, at magnification 10X.  Arrows are pointing 
to various Ventral Pallidal cell bodies expressing mCherry/DREADDs.  
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DISCUSSION 
 
 
The expectation of this study was that all rat phenotypes would show increases in 
sign-tracking behavior in Pavlovian Conditioned Approach sessions after receiving an 
injection of CNO.  Although we can confirm DREADD expression in the subjects tested 
on, and in vivo studies have shown that systemic CNO can activate DREADDs located in 
the brain, we have no way of showing that the DREADDs were activated following each 
CNO injection in this current study, though modifications to the study can be made to 
remedy this issue.  Showing that changes in neural firing take place in the VP and in the 
VTA as a result of a CNO injection is possible with an electrode implant, which will be 
addressed further on in this discussion. 
The best measure of an effect of CNO treatment, by means of calculating 
difference scores, showed that the difference between baseline PCA behavior and CNO-
activated DREADD influenced behavior is a decrease in lever latency in Sign Trackers, 
but not in Goal Trackers or Intermediates.  This effect was also only evident on certain 
testing days, which was not expected but may be due to troubleshooting errors with the 
Pavlovian conditioning chambers (problems with pellet delivery into the magazine on a 
given day) or problems with the CNO dose getting to the DREADDs from their site of 
injection.  The results therefore fail to reach significance for multiple behavioral 
measures or across all rat phenotypes and the original hypothesis cannot be confirmed.  
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However, the significant findings and overall trends seen from data analysis provide an 
opportunity to devise future studies. 
It is possible that the effects of CNO-activated DREADDs are making Sign 
Trackers more attracted to the cue, which would prompt them to approach it more 
quickly than usual.  An explanation for this trend not being consistent among the other rat 
phenotypes can be attempted.  It is possible that Goal Trackers and Intermediates are 
noticing the lever more quickly, but their behavior towards the lever may be different 
than in Sign Trackers. Perhaps the non-sign-tracking group would enter the magazine 
more quickly after observing the cue with heightened sensitivity.  However, a trend that 
is not apparent is a decreased latency to enter the magazine in GTs/INTs, meaning if the 
rats are paying attention to the lever, they aren’t using the cue as an indication to more 
quickly enter the magazine.  What may be occurring is a shift in goal tracking towards 
sign tracking without adequate lever deflections as evidence.   
A limitation of this study was that no video recordings of the subjects performing 
their PCA behavior took place.  A prior study paired cocaine delivery with a lever and 
found that, compared to rats who were exposed to the same cue but received cocaine 
delivery in an unpaired manner, the rats in the paired group instilled incentive salience 
onto the lever and the lever latency decreased (Uslaner et al. 2006).  This same study 
demonstrated that the paired group of rats did not have a shorter latency to approach the 
lever until 15 days of the cocaine-lever pairing had taken place.  The most noteworthy 
finding was that lever interaction was not solely based on lever presses.  Instead, rats 
would orient themselves to the lever when it was presented, approach the lever and 
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engage it in the form of sniffing.  These rats were valuing the lever and exhibiting a 
decreased lever latency, but those results did not show up in the form of lever presses, 
rather in analysis of video records (Uslaner et al. 2006).   
From these findings, two modifications to this study can take place.  First, video 
recording animals would show more diverse rat behavior that is indicative of incentive 
salience imparting onto the lever.  Second, testing days should be extended.  The current 
study observed rat behavior during and across five days where CNO was used to activate 
inhibitory DREADDs in the Ventral Pallidum.  Testing the effects of daily CNO 
injections on rats for a two week duration may show more pronounced levels of the faint 
trends noticeable from this study and will bring more clarity to the overall effects of the 
DREADDs being activated by CNO treatment. 
An equally important extension of this improvement would be to extend testing 
days in the control (saline) testing as well.  The results here show a trend in Goal 
Trackers toward sign tracking over time, but there is also a similar, although much more 
subtle, trend taking place across the saline testing days.  A study showing that a trend 
toward sign tracking does not occur with two consecutive weeks of saline injections 
would help prove that the changes observed were due to CNO-activated DREADDs and 
not an effect of sensitization to the lever from testing rats for too long under the PCA 
paradigm, which has not been demonstrated in studies but, if it were taking place, could 
account for a decrease in magazine entries shown in the GT/INT group. 
There is some evidence presented here that suggests the role of the Ventral 
Pallidum is to provide the “brakes” in terms of attributing incentive salience to a reward 
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cue and that when these brakes are lifted in the form of inhibitory designer receptors, rats 
impart more incentive salience onto reward-predicting stimuli.  Inhibition of the VP to 
VTA pathway has shown some transient changes in rats who are already susceptible to 
sign tracking and it has also shown more gradual changes over time in Goal Trackers, 
who do not tend to value the lever as Sign Trackers do.  If the original hypothesis of this 
study is true, the mechanism of causing increased sign tracking cannot be known with 
certainty because this study has no way of proving if disinhibition was caused in the 
VTA.  Although the original expectation was that VTA disinhibition would occur from 
VP inhibition, the heterogeneous cells that populate the VTA make that theory a difficult 
one to prove. 
The VTA contains Dopamine, GABA and Glutamate neurons (Morales and 
Margolis 2017) (Faget et al. 2016).  The VP is one of the main projection sites for the 
VTA, with VP projections synapsing onto the three VTA cell types (DA, GABA, 
glutamate) fairly evenly, though results showed that slightly more input went to the DA 
neurons in particular (Faget et al. 2016).  Although this study targeted dopaminergic cells 
in the VTA that encode incentive salience, the method of targeting the VTA was based on 
the axonal projections of cells in the VP, and those axons could synapse onto a variety of 
cell types within the VTA.   
The GABA interneurons in the VTA may play a critical role in regulation of 
activity of the DA cells in the VTA (Nair-Roberts et al. 2008).  An in vitro study has 
shown that GABAergic neurons in VTA inhibit dopaminergic VTA neurons (Dobi et al. 
2010).  Additionally, the GABAergic neurons in the VTA have been shown to be 
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inhibited by some drugs of abuse (Lüscher and Malenka 2011), which causes 
disinhibition of the local (VTA) dopamine neurons (Bocklisch et al. 2013), (Floresco et 
al. 2003).  It is possible that some of the VP cell bodies that received inhibitory 
DREADDs ended up impacting GABAergic neurons in the VTA, which would produce 
the overall effect of inhibition of those DA cells in the VTA.  Another possibility is that 
the DA cells within the VTA were directly impacted by the inhibitory DREADDs as 
expected, but there are also differences among VTA dopaminergic cells to consider. 
The VTA contains DA neurons that carry out different functions, depending on 
the brain structures they project onto (Juarez and Han 2016).  Not only are the cell types 
within the VTA diverse then, but the dopaminergic cells carry out diverse functions as 
well.  In vivo single-cell recordings of DA neurons in the VTA have shown that there are 
two different firing patterns present – tonic firing, which is single-spike activity with 
slow frequency, and phasic firing, a multi-spike activity (Cao et al. 2010), (Grace et al. 
2007).  Studies have shown the VP’s hold on the VTA is important for tonic release of 
dopamine (Floresco et al. 2003).  The tonic DA transmission was targeted with this study 
because it is responsible for prolonged DA actions (Wightman and Robinson 2002) and 
increased tonic DA activity in the VTA after VP GABAergic inhibition has been shown 
to produce increased dopamine in the NAc (Floresco et al. 2003).  In future studies, this 
specific dopamine transmission can be looked at to see if more tonic release of dopamine 
in turn causes more or less phasic (burst firing) DA release during Pavlovian conditioned 
approach and reward processing.  This would be an opportunity to investigate 
mesolimbic dopamine systems that are more or less excitable (Alcaro, Huber, and 
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Panksepp 2007) in terms of dopamine responses to reward and cues predicting reward, 
which would influence the relative impact drugs of abuse may cause on the system. 
One way to ensure that the inhibitory DREADDs in the VP are causing 
disinhibition of the VTA with increased dopaminergic firing would be to add an element 
onto this study, electrophysiology.  Implanting a unilateral electrode into a rat brain to 
record from two brain areas would be beneficial because it could show neural activity in 
one brain area and downstream activity in another area.  The electrode could allow 
recording from the VP to show less firing of GABA neurons, along with recording from 
the VTA, which would possibly show increased tonic firing of dopamine cells.  This 
addition would also be a way to show how the neurons are being affected by CNO 
injections on a given day.  Although CNO injection amounts are kept constant and the 
amounts given are based on guidelines for eliciting behavioral changes, a systemic 
injection as a method of activating DREADDs isn’t entirely precise (Urban and Roth 
2015).  It is not currently known how much the neural circuits are being affected by the 
drug, despite our efforts to map out a time span in hopes of seeing its effects. 
Whether the targeted VP to VTA pathway is implicated in predisposing rats to 
impart incentive salience onto a reward-predicting cue, along with whether that pathway 
can be manipulated to shift a rat’s underlying behavioral tendencies, remains to be 
confirmed.  An additional study that can uncover changed behavior in Goal Trackers and 
Intermediates with video analysis, along with neuronal recording during PCA sessions 
via electrode implantation, is a direction that may lead to better understanding of this 
mesolimbic neural pathway.  
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